Trevena Inc (TRVN)
0.391
-0.02
(-4.40%)
USD |
NASDAQ |
Apr 26, 16:00
0.40
+0.01
(+2.30%)
After-Hours: 20:00
Trevena Total Liabilities (Quarterly): 48.26M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 48.26M |
September 30, 2023 | 41.58M |
June 30, 2023 | 29.08M |
March 31, 2023 | 28.14M |
December 31, 2022 | 33.08M |
September 30, 2022 | 29.16M |
June 30, 2022 | 28.86M |
March 31, 2022 | 15.02M |
December 31, 2021 | 15.50M |
September 30, 2021 | 13.93M |
June 30, 2021 | 21.69M |
March 31, 2021 | 20.43M |
December 31, 2020 | 23.67M |
September 30, 2020 | 11.36M |
June 30, 2020 | 11.00M |
March 31, 2020 | 10.26M |
December 31, 2019 | 16.92M |
September 30, 2019 | 22.19M |
June 30, 2019 | 22.79M |
March 31, 2019 | 25.50M |
December 31, 2018 | 25.25M |
September 30, 2018 | 27.47M |
Date | Value |
---|---|
June 30, 2018 | 33.63M |
March 31, 2018 | 32.32M |
December 31, 2017 | 38.09M |
September 30, 2017 | 37.43M |
June 30, 2017 | 36.40M |
March 31, 2017 | 35.84M |
December 31, 2016 | 36.07M |
September 30, 2016 | 29.44M |
June 30, 2016 | 27.59M |
March 31, 2016 | 28.28M |
December 31, 2015 | 32.22M |
September 30, 2015 | 12.93M |
June 30, 2015 | 15.31M |
March 31, 2015 | 16.10M |
December 31, 2014 | 9.035M |
September 30, 2014 | 9.697M |
June 30, 2014 | 5.602M |
March 31, 2014 | 5.308M |
December 31, 2013 | 3.401M |
September 30, 2013 | 3.733M |
June 30, 2013 | 3.935M |
December 31, 2012 | 8.127M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.26M
Minimum
Mar 2020
48.26M
Maximum
Dec 2023
23.31M
Average
22.19M
Median
Sep 2019
Total Liabilities (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 5.72M |
Palatin Technologies Inc | 24.94M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 15.52M |
Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 40.60M |
Shareholders Equity (Quarterly) | -7.657M |
Debt to Equity Ratio | -4.024 |
Current Ratio | 4.660 |
Net Debt Paydown Yield | -27.68% |